Correlation Between Memphis Pharmaceuticals and B Investments

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Memphis Pharmaceuticals and B Investments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memphis Pharmaceuticals and B Investments into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Memphis Pharmaceuticals and B Investments Holding, you can compare the effects of market volatilities on Memphis Pharmaceuticals and B Investments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memphis Pharmaceuticals with a short position of B Investments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memphis Pharmaceuticals and B Investments.

Diversification Opportunities for Memphis Pharmaceuticals and B Investments

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between Memphis and BINV is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Memphis Pharmaceuticals and B Investments Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on B Investments Holding and Memphis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memphis Pharmaceuticals are associated (or correlated) with B Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of B Investments Holding has no effect on the direction of Memphis Pharmaceuticals i.e., Memphis Pharmaceuticals and B Investments go up and down completely randomly.

Pair Corralation between Memphis Pharmaceuticals and B Investments

Assuming the 90 days trading horizon Memphis Pharmaceuticals is expected to under-perform the B Investments. In addition to that, Memphis Pharmaceuticals is 3.82 times more volatile than B Investments Holding. It trades about -0.1 of its total potential returns per unit of risk. B Investments Holding is currently generating about -0.1 per unit of volatility. If you would invest  2,545  in B Investments Holding on September 24, 2024 and sell it today you would lose (50.00) from holding B Investments Holding or give up 1.96% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Memphis Pharmaceuticals  vs.  B Investments Holding

 Performance 
       Timeline  
Memphis Pharmaceuticals 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
B Investments Holding 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in B Investments Holding are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, B Investments may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Memphis Pharmaceuticals and B Investments Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Memphis Pharmaceuticals and B Investments

The main advantage of trading using opposite Memphis Pharmaceuticals and B Investments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memphis Pharmaceuticals position performs unexpectedly, B Investments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in B Investments will offset losses from the drop in B Investments' long position.
The idea behind Memphis Pharmaceuticals and B Investments Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Fundamental Analysis
View fundamental data based on most recent published financial statements
FinTech Suite
Use AI to screen and filter profitable investment opportunities